ObsEva Announces Presentation of Clinical Data on Oral GnRH Antagonist Linzagolix at ASRM 2021 ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

Geneva ,Genè ,Switzerland ,United States ,American ,Swiss ,Shauna Dillon ,Jacques Donnez ,Joyce Allaire ,Exchange Commission ,Administration Of Hormonal ,Scientific Congress Expo ,American Society For Reproductive Medicine ,Swiss Exchange ,Switzerland October ,American Society ,Reproductive Medicine ,Severe Adenomyosis ,Final Results ,Hormonal Add Back Therapy ,Uterine Volume Reducing Effects ,Nasdaq Global Select Market ,Note Regarding Forward Looking Statements ,Private Securities Litigation Reform Act ,Risk Factors ,Annual Report ,Business ,Health ,Globe Newswire ,Obseva Sa ,Uterine Fibroids ,